Back to Search
Start Over
Supplementary Figure S1 from The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Subgroup analysis of (A) ORR, (B) DOR and (C) PFS confirmed by investigator
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....c0374988e3c67e415c7591be1a3c9aff
- Full Text :
- https://doi.org/10.1158/1078-0432.22490801